Please use this identifier to cite or link to this item:
https://doi.org/10.48548/pubdata-129
Full metadata record
| Field | Value |
|---|---|
| Resource type | Journal Article |
| Title(s) | Towards the design of active pharmaceutical ingredients mineralizing readily in the environment |
| DOI | 10.48548/pubdata-129 |
| Handle | 20.500.14123/148 |
| Creator | Puhlmann, Neele  0000-0002-9397-2540 (Institut für Nachhaltige Chemie (INSC), Leuphana Universität Lüneburg  02w2y2t16)Mols, Renate (Van 't Hoff Institute for Molecular Sciences, University of Amsterdam) Olsson, Oliver 0000-0003-0082-1442 (Institut für Nachhaltige Chemie (INSC), Leuphana Universität Lüneburg 02w2y2t16)Slootweg, Chris 0000-0001-7818-7766 (Van 't Hoff Institute for Molecular Sciences, University of Amsterdam)Kümmerer, Klaus 0000-0003-2027-6488  118066382 (Institut für Nachhaltige Chemie (INSC), Leuphana Universität Lüneburg 02w2y2t16) |
| Abstract | Active pharmaceutical ingredients (APIs), their metabolites, and transformation products (TPs) occur globally in the environment. They pose a risk to both environmental and human health. These alarming circumstances highlight the strong need for efficient measures, which is also reflected in EU strategies on sustainable chemicals and on pharmaceuticals in the environment. The design of APIs for mineralization in the environment according to the concept Benign by Design (BbD) is a promising approach to tackle this challenge. However, its implementation into the industrial API discovery process has not been discussed yet. To stimulate such a discussion and to better understand the applicability and limitations of this approach, the generic API discovery process is reviewed, including procedure, principles, and paradigms based on publicly available information. In addition to the concept of BbD itself, workflow scenarios such as de novo design and re-design are presented to provide a better understanding of its feasibility. Bringing these aspects together, we conclude that the optimization phase within drug discovery seems to be the most appropriate place to implement environmental considerations. At this early stage, costs are low and the potential impact of design and structural variation on the outcome is high. We found that pharmacological parameters required for application are sometimes even in line with biodegradability in the environment, since the conditions in the human body and the environment differ. However, the effects of optimizing pharmacological parameters such as toxicity and stability on environmental biodegradability of APIs must be considered together with design rules for biodegradability. Understanding the feasibility of BbD can mitigate the concerns pointed out by stakeholders and encourage them to invest in research and development, as well as support pharmaceutical companies to be prepared for upcoming regulations, since the aforementioned EU strategies announce further political regulations. We found also that successful implementation of BbD depends on the availability of suitable tools and methods as well as on incentives for research and development within constructive collaboration of industry, academia, and authorities. |
| Language | English |
| Keywords | Active Pharmaceutical Ingredients; API; Benign by Design; Green Pharmacy; Sustainable Pharmacy; Drug Discovery; Biodegradability |
| Thematic Classification | Green Pharmacy |
| DDC | 540 :: Chemie und zugeordnete Wissenschaften |
| Year of publication in PubData | 2024 |
| Publishing type | Parallel publication |
| Publication version | Accepted version |
| Date issued | 2021-06-21 |
| Creation context | Research |
| Faculty / department | Fakultät Nachhaltigkeit |
| Date of Availability | 2024-01-22T08:36:23Z |
| Archiving Facility | Medien- und Informationszentrum (Leuphana Universität Lüneburg 02w2y2t16) |
| Published by | Medien- und Informationszentrum, Leuphana Universität Lüneburg |
Information regarding first publication
| Field | Value |
|---|---|
| Resource type | Journal |
| Title of the resource type | Green Chemistry |
| Identifier | DOI: 10.1039/D1GC01048D |
| Publication year | 2021 |
| Volume | 23 |
| Issue | 14 |
| Pages | 5006 - 5023 |
| Publisher | Royal Society of Chemistry |
Related Resources
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
puhlmann_2021_towards_the_design_of_active_pharmaceutical_ingredients.pdf License: 
open-access | 1.25 MB | Adobe PDF | View/Open |
Items in PubData are protected by copyright, with all rights reserved, unless otherwise indicated.
Views
BibTeX
RIS
Item Export Bar
Datacite XML
OpenAIRE4
Access statistics
Page view(s): 112
Download(s): 29